DBPR112
DBPR112 is an orally active furanopyrimidine-based EGFR inhibitor with IC50s of 15 nM for EGFRWT and 48 nM for EGFRL858R/T790M, capable of occupying the ATP-binding site and demonstrating significant antitumor efficacy.
Product Specifications
CAS Number
1226549-49-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
533.62
Molecular Formula
C32H31N5O3
Notes
Research use only, not for human use.
Receptor
EGFR
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15078691 1 Vial
Lentiviral human CARMIL3 shRNA (UAS) - Lentiviral human CARMIL3 shRNA (UAS) plasmid
Sign In for Pricing
View Details 
MBS1326016-01 0.02 mg (E-Coli)
Recombinant Hahella chejuensis Acetylglutamate kinase (argB)
Sign In for Pricing
View Details 
MBS1326016-02 0.02 mg (Yeast)
Recombinant Hahella chejuensis Acetylglutamate kinase (argB)
Sign In for Pricing
View Details MBS1326016-03 0.1 mg (E-Coli)
Recombinant Hahella chejuensis Acetylglutamate kinase (argB)
Sign In for Pricing
View Details MBS1326016-04 0.1 mg (Yeast)
Recombinant Hahella chejuensis Acetylglutamate kinase (argB)
Sign In for Pricing
View Details